Both lncRNAs are downregulated in NSCLC, and their function opposes oncogenic lncRNA FAL1-BMI1 that downregulates PTEN to enhance AKT-induced tumorigenesis [42,109,111]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.